Monitoring ventricular contractions using an implantable stimulation device

• US 7,212,861 B1
• Filed: 05/03/2004
• Issued: 05/01/2007
• Est. Priority Date: 05/03/2004
• Status: Active Grant

• Current Assignee: Pacesetter Incorporated (Abbott Laboratories)
• Original Assignee: Pacesetter Incorporated (Abbott Laboratories)
• Inventors: Bornzin, Gene A., Park, Euljoon, Turcott, Robert G.
• Primary Examiner(s): Pezzuto; Robert E.
• Assistant Examiner(s): Gedeon; Brian T.
• Application Number:
  US10/838,939
• Time in Patent Office: 1,093 Days
• Field of Search: 600/486, 607 17- 19
• US Class Current: 607/17
• CPC Class Codes: A61N 1/3627 for treating a mechanical deficiency of the heart, e.g. congestive heart failure or cardiomyopathy
• CPC Class Codes: A61N 1/36585 controlled by two or more physical parameters

Abstract

An implantable cardiac stimulation device is configured to measure selected ventricular contraction parameters and possibly apply stimulation therapy based on the ventricular contraction parameters. In accordance with one aspect, the ventricular contraction parameters include impedance values that correspond to the volume of fluid in the right ventricle and the left ventricle. In accordance with another aspect, the ventricular contraction parameters include motion values that correspond to heart sounds/motion in the right ventricle and the left ventricle. The ventricular contraction parameters can be used to form pseudo P-V loop from which treatment decisions can be made.

Claims

1. A method for use with an implantable cardiac stimulation device, the method comprising:

collecting plethysmogram data from a location outside the bloodstream during at least one cardiac cycle;

determining ventricular pressure data for the at least one cardiac cycle; and

processing the plethysmogram data as a function of the pressure data to produce data corresponding to a ventricular contraction loop.

2. The method as recited in claim 1, further comprising:

applying stimulation therapy to at least one ventricle based on the data corresponding to a ventricular contraction loop.

3. The method as recited in claim 1, further comprising:

transmitting the data corresponding to a ventricular contraction loop to at least one external device.

4. The method as recited in claim 2, further comprising:

determining boundary values as defined by the data corresponding to a ventricular contraction loop for the at least one cardiac cycle.

5. The method as recited in claim 4, further comprising:

adjusting the stimulation therapy such that subsequent boundary values fall within a predetermined range of acceptable boundary values.

6. The method as recited in claim 1, wherein:

processing the plethysmogram data as a function of the pressure data comprises processing the plethysmogram data to derive a metric of ventricular volume which is then processed as a function of the pressure data to produce data corresponding to a ventricular contraction loop.

7. The method as recited in claim 1, wherein determining ventricular pressure data for the at least one cardiac cycle comprises:

collecting ventricular motion data during the at least one cardiac cycle, and processing the ventricular motion data to derive a metric of ventricular pressure.

8. The method as recited in claim 1, wherein determining ventricular pressure data for the at least one cardiac cycle comprises:

collecting ventricular pressure data from within the ventricle during the at least one cardiac cycle.

9. The method as recited in claim 1, wherein determining ventricular pressure data for the at least one cardiac cycle comprises computing a derivative of the plethysmogram data collected during the at least one cardiac cycle to derive a metric of ventricular pressure.

10. An implantable cardiac stimulation device comprising:

means for collecting plethysmogram data from a location outside the bloodstream during at least one cardiac cycle;

means for determining ventricular pressure data for the at least one cardiac cycle; and

means for processing the plethysmogram data as a function of the pressure data to produce data corresponding to a ventricular contraction loop.

11. The implantable cardiac stimulation device as recited in claim 10, further comprising:

means for applying stimulation therapy to at least one ventricle based on the data corresponding to a ventricular contraction loop.

12. The implantable cardiac stimulation device as recited in claim 10, further comprising:

means for transmitting the data corresponding to a ventricular contraction loop to at least one external device.

13. The implantable cardiac stimulation device as recited in claim 10, and further comprising:

means for determining boundary values as defined by the data corresponding to a ventricular contraction loop for the at least one cardiac cycle.

14. The implantable cardiac stimulation device as recited in claim 13, further comprising:

means for adjusting the stimulation therapy such that subsequent boundary values fall within a predetermined range of acceptable boundary values.

15. The implantable cardiac stimulation device as recited in claim 10, wherein:

the means for processing the plethysmogram data as a function of the pressure data comprises means for processing the plethysmogram data to derive a metric of ventricular volume which is then processed as a function of the pressure data to produce data corresponding to a ventricular contraction loop.

16. The implantable cardiac stimulation device as recited in claim 10, and further comprising wherein means for determining ventricular pressure data for the at least one cardiac cycle comprises:

means for collecting ventricular motion data during the at least one cardiac cycle, and processing the ventricular motion data to derive a metric of ventricular pressure.

17. The implantable cardiac stimulation device as recited in claim 10, and further comprising wherein determining ventricular pressure data for the at least one cardiac cycle comprises:

means for collecting ventricular pressure data from within the ventricle during the at least one cardiac cycle.

18. The implantable cardiac stimulation device as recited in claim 10, wherein the means for determining ventricular pressure data for the at least one cardiac cycle comprises means for computing a derivative of the plethysmogram data collected during the at least one cardiac cycle to derive a metric of ventricular pressure.